Announced Fri, 26 Jun · 20:21 IST
Trading Window closed from 1 July 2026 for Q1 results
Compliance View source PDF
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.8%1-day move
₹456.60
prior close
₹456.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.4-1.0-1.2+0.4-0.8-1.3-0.4-0.5-1.4-4.9-1.6———
Up moveDown movePending
AI summary
Cohance Lifesciences has closed its trading window from 1 July 2026 until 48 hours after declaring unaudited financial results for the quarter ending 30 June 2026. This is a routine SEBI insider trading compliance measure applying to designated persons and their immediate relatives. Board meeting date for Q1 results will be announced later. (Formerly Suven Pharmaceuticals)
Likely market impact
Routine compliance filing. No direct stock impact. Watch for upcoming Q1 FY27 results announcement.